Mikael Kowal

Chief Scientific Officer

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mikael Kowal is the Chief Scientific Officer at Bedrocan International BV in the Netherlands. His research primarily focuses on the therapeutic applications of cannabis, particularly in pain management and safety assessments of cannabinoid-based treatments. Recent publications include investigations into the effects of cannabis combined with opioids for fibromyalgia pain relief and the respiratory effects of inhaled Δ9-tetrahydrocannabinol.

Articles (3)

Year:

2024

Year:

2024

Year:

2023

Collaborators (1)

Albert Dahan

Professor

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mikael Kowal

Research Interests

Explore related searches

Contact this professor

About

Articles (3)

Cannabis combined with oxycodone for pain relief in fibromyalgia pain: a randomized clinical self-titration trial with focus on adverse events

The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review

Inhaled Δ<sup>9</sup>-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteers.

Collaborators (1)

Albert Dahan

Make your next move.